{
    "Trade/Device Name(s)": [
        "Dario Blood Glucose Monitoring System"
    ],
    "Submitter Information": "LabStyle Innovations",
    "510(k) Number": "K163159",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150817"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "July 19, 2017",
    "Summary Letter Received Date": "June 19, 2017",
    "Submission Date": "June 15, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dario Blood Glucose Meter",
        "Smart Mobile Device (SMD)"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Software",
        "App"
    ],
    "Document Summary": "FDA 510(k) summary for the Dario Blood Glucose Monitoring System, a compact meter used with a smart mobile device to quantitatively measure glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood samples from the fingertip by people with diabetes at home to monitor diabetes control; not for diagnosis or screening of diabetes or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}